Please provide your email address to receive an email when new articles are posted on . Data show early anticoagulation after acute stroke in people with atrial fibrillation is safe when indicated.

As one of the most powerful independent risk factors for ischemic stroke and the most clinically relevant arrhythmia, atrial fibrillation (AF) poses a serious clinical and public health threat as the ...

Many patients with atrial fibrillation are not taking oral anticoagulation because of an elevated bleeding risk, and this subset faces substantial risks of both ischemic and hemorrhagic stroke, a new ...

Please provide your email address to receive an email when new articles are posted on . Inadequate anticoagulation occurred often in patients with atrial fibrillation who had an acute ischemic stroke, ...

Patients with A-fib who have an ischemic stroke fare much better in subsequent years if they’re taking oral anticoagulation as opposed to antiplatelets alone or nothing at all, results from a new ...

Patients with embolic stroke of undetermined source (ESUS) who are found to have signs of left ventricular dysfunction may benefit from anticoagulation to prevent a further stroke, a new exploratory ...

The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...

The anticoagulant medication dabigatran yielded similar results to warfarin for the prevention of cognitive decline in older adults with atrial fibrillation after two years of treatment, according to ...

A new study has found that dementia rates increase when anticoagulation treatment is delayed for patients with atrial fibrillation, the most common heart arrhythmia in the world that affects more than ...

The presence of microbleeds in the brain should not affect the decision to prescribe anticoagulation to patients after an ischemic stroke, new data suggest. "We found that microbleeds increased the ...

CHICAGO – Although current guidelines recommend 3 months of anticoagulation treatment after bioprosthetic aortic valve replacement surgery, a study that included more than 4,000 patients found that ...